Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine in Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT03702985Phase 2Unknown
- Sponsor
- Fudan University
- Start
- May 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in rectal cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
amifostine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03702985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702985.